Patterns Of Drug Use In Patients With Knee Osteoarthritis At The Bina Sehat Jember Hospital
DOI:
https://doi.org/10.22219/sm.Vol18.SMUMM2.19748Abstract
Osteoarthritis is a degenerative disease characterized by progressive damage to joint cartilage. The prevalence of osteoarthritis will continue to increase and continue as the population and age increase. Cases of knee osteoarthritis are more common than other types of osteoarthritis. The high prevalence of osteoarthritis will have implications for the high treatment regimen given to patients. Irrational use of drugs can lead to drug-related problems (DRPs). This study used a descriptive design. The sample in this study were knee osteoarthritis patients at the Bina Sehat Jember Hospital. The sampling technique used is purposive sampling. The data in this study used secondary data from patient medical records for the period January 2020 - April 2021. A total of 3 knee osteoarthritis patients have the potential to experience drug-related problems in the drug interaction category.
Downloads
References
Alwi, I., Salim, S., Hidayat, R., Kurniawan, J., & Tahapary, D. L. (2016). Panduan Praktik Klinis Penatalaksanaan di Bidang Ilmu Penyakit Dalam (1st ed.). Interna Publishing.
Bruyère, O., Honvo, G., Veronese, N., Arden, N. K., Branco, J., Bruy, O., Curtis, E. M., Al-daghri, N. M., Herrero-beaumont, G., Roth, R., Uebelhart, D., & Cooper, C. (2019). An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (ESCEO). Seminars in Arthritis and Rheumatism, 49(3), 337–450. https://doi.org/10.1016/j.semarthrit.2019.04.008
Chincholkar, M. (2018). Analgesic mechanisms of gabapentinoids and effects in experimental pain models: a narrative review. British Journal of Anaesthesia, 120(6), 1315–1334. https://doi.org/10.1016/j.bja.2018.02.066
Contartese, D., Tschon, M., De Mattei, M., & Fini, M. (2020). Sex specific determinants in osteoarthritis: A systematic review of preclinical studies. International Journal of Molecular Sciences, 21(10). https://doi.org/10.3390/ijms21103696
Drugs.com. (2021). Drug Interactions checker from Drugs.com. https://www.drugs.com/drug_interactions.html
Enteshari-moghaddam, A., Azami, A., Isazadehfar, K., Mohebbi, H., & Habibzadeh, A. (2019). Efficacy of duloxetine and gabapentin in pain reduction in patients with knee osteoarthritis. Clinical Rheumatology, 38, 2873–2880.
Fathnin, F. H., Yuniastuti, A., & Kasmini, O. W. (2020). The Relation of Drug Amount, Comorbidity, Blood Pressure, and Residential Area to Drug-Related-Problems of Hypertension Patients. Public Health Perspectives Journal Fildza Huwaina Fathnin, 5(3), 2020–2178. http://journal.unnes.ac.id/sju/index.php/phpj
Garfinkel, R. J., Dilisio, M. F., & Agrawal, D. K. (2017). Vitamin D and Its Effects on Articular Cartilage and Osteoarthritis. Orthopaedic Journal of Sports Medicine, 5(6), 1–8. https://doi.org/10.1177/2325967117711376
Gunawan, S. G., Setiabudy, R., Nafrialdi, & Istiaty. (2016). Farmakologi dan Terapi. Universitas Indonesia.
Gupta, R., Malhotra, A., & Malhotra, P. (2018). Study of prescription pattern of drugs used in the treatment of osteoarthritis in a tertiary care teaching hospital: an observational study. International Journal of Research in Medical Sciences, 6(7), 2380. https://doi.org/10.18203/2320-6012.ijrms20182821
Katzung, B. G., Masters, S. B., & Trevor, A. J. (2014). Farmakologi Dasar & Klinik (12th ed.). EGC.
Khotib, J., Setiawan, H. U., Nurhan, A. D., Rahadiansyah, E., Ardianto, C., & Rahmadi, M. (2019). Analysis of effectiveness and drug related problems of pain reliever for knee osteoarthritis: Weighing clinical risk and benefit. Journal of Basic and Clinical Physiology and Pharmacology, 30(6), 1–9. https://doi.org/10.1515/jbcpp-2019-0338
Kolasinski, S. L., Neogi, T., Hochberg, M. C., Oatis, C., Guyatt, G., Block, J., Callahan, L., Copenhaver, C., Dodge, C., Felson, D., Gellar, K., Harvey, W. F., Hawker, G., Herzig, E., Kwoh, C. K., Nelson, A. E., Samuels, J., Scanzello, C., White, D., … Reston, J. (2020). 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis and Rheumatology, 72(2), 220–233. https://doi.org/10.1002/art.41142
Lovell, A. R., & Ernst, M. E. (2017). Drug-Induced Hypertension: Focus on Mechanisms and Management. Current Hypertension Reports, 19:39.
Lung, B. E., Mowery, M. L., & Komatsu, D. E. E. (2021). Calcitriol. XPharm: The Comprehensive Pharmacology Reference, 1–5. https://www.ncbi.nlm.nih.gov/books/NBK526025/
MIMS. (2019). MIMS Drug Reference (C. H. Kian (ed.); 142nd ed.). PT Medidata Indonesia.
Muslim, A. T. N., Hakim, A., & Dianti, M. R. (2018). Identification of Potential Drug Related Problems of Improper Dosage and Adverse Drug Reactions Categories in Osteoarthritis Outpatients in Rsud Jombang 2016. Journal of Islamic Pharmacy, 3(1), 23. https://doi.org/10.18860/jip.v3i1.4994
Nieves-Plaza, M., Castro-Santana, L. E., M. Font, Y., Mayor, A. M., & Vilá, L. M. (2013). Association of hand or knee osteoarthritis with diabetes mellitus in a population of Hispanics from Puerto Rico. Early Human Development, 83(1), 1–11. https://doi.org/10.1016/j.earlhumdev.2006.05.022
Palazzo, C., Nguyen, C., Lefevre-Colau, M. M., Rannou, F., & Poiraudeau, S. (2016). Risk factors and burden of osteoarthritis. Annals of Physical and Rehabilitation Medicine, 59(3), 134–138. https://doi.org/10.1016/j.rehab.2016.01.006
Pharmaceutical Care Network Europe Association. (2019). Classification for Drug related problems © 2003-2017. The PCNE Classification V 9.00, 1–10. https://www.pcne.org/upload/files/334_PCNE_classification_V9-0.pdf
Piva, S. R., Susko, A. M., Khoja, S. S., Josbeno, D. A., Fitzgerald, G. K., & Toledo, F. G. S. (2015). Links between osteoarthritis and diabetes: Implications for management from a physical activity perspective. Clinics in Geriatric Medicine, 31(1), 67–87. https://doi.org/10.1016/j.cger.2014.08.019
Riskesdas. (2013). Riset Kesehatan Dasar. Badan Penelitian dan Pengembangan Kesehatan Kementerian RI. https://doi.org/10.1126/science.127.3309.1275
Setiati, S., Alwi, I., Sudoyo, A. W., Simadribata, M., Setyohadi, B., & Syam, A. F. (2014). Buku Ajar Ilmu Penyakit Dalam (6th ed.). Interna Publishing.
Sherman, A. L., Ojeda-Correal, G., & Mena, J. (2012). Use of Glucosamine and Chondroitin in Persons With Osteoarthritis. PM and R, 4(5 SUPPL.), 110–116. https://doi.org/10.1016/j.pmrj.2012.02.021
Soeroso, J., Harry, I., Handono, K., Rawan, B., & Riardi, P. (2014). Buku Ajar Ilmu Penyakit Dalam (6th ed.). Interna Publishing.
Suyasa, I., & Setiawan, I. (2016). The role of aging, body mass index and estrogen on symptomatic lumbar osteoarthritis in post-menopausal women. International Journal of Research in Medical Sciences, 4(5), 1325–1328. https://doi.org/10.18203/2320-6012.ijrms20161003
Verma, N., Singh, A., Ali, S., & Yadav, M. (2017). Analysis of Hypertension as a Risk Factor for Osteoarthritis Knee. Hypertension Journal, 3(4), 167–170. https://doi.org/10.5005/jp-journals-10043-0089
Wijaya, S. (2018). Osteoartritis Lutut. Cermin Dunia Kedokteran, 45(6), 424–429.
Wittenauer, R., Smith, L., & Aden, K. (2013). Priority Medicines for Europe and the World " A Public Health Approach to Innovation ". 1–31. http://www.who.int/medicines/areas/priority_medicines/BP6_12Osteo.pdf
Xiong, J., Long, J., Chen, X., Li, Y., & Song, H. (2020). Dyslipidemia Might Be Associated with an Increased Risk of Osteoarthritis. BioMed Research International, 2020, 1–9. https://doi.org/10.1155/2020/3105248
Zhijun, L., Rongchun, C., Feixiang, L., Yaohong, W., Ning, L., Shufang, Z., Mingliang, Z., & Hongfa, Z. (2019). Therapeutic effects of combined meloxicam and glucosamine sulfate treatment on patients with osteoarthritis, and its effect on serum CTX-I, CTX-II, COMP and MMP-3. Tropical Journal of Pharmaceutical Research, 18(7), 1553–1557. https://doi.org/10.4314/tjpr.v18i7.28
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Desie Dwi Wisudanti, Firman Pratama Andraputra, Muhammad Ali Shodikin
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
